Advertisement

Topics

Latest "JA Kemp & co" News Stories

17:19 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "JA Kemp & co" found in our extensive news archives from over 250 global news sources.

More Information about JA Kemp & co on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about JA Kemp & co for you to read. Along with our medical data and news we also list JA Kemp & co Clinical Trials, which are updated daily. BioPortfolio also has a large database of JA Kemp & co Companies for you to search.

Showing "Kemp" News Articles, all 12

Wednesday 18th July 2018

Extended genetic testing and GYN cancer risk

Dr Kemp speaks with ecancer at BCGS 2018 about determining inherited risks to ovarian cancer. She outlines the availability of genetic screening for patients and their family, and the overlap with genetic screening programmes for breast cancer. Dr Kemp...


Monday 16th July 2018

QT Ultrasound® Chooses Centrify to Strengthen HIPAA Compliance

Zero Trust Security enables medical technology pioneer to remain laser-focused on saving lives Centrify, a leading provider of Zero Trust Security through the power of Next-Gen Access, today announced medical technology pioneer QT Ultrasound has selected the Centrify

Monday 18th June 2018

Intercytex reforms as U.S Department of defence funds Vavelta Scar Therapy trials for injured soldiers

Intercytex, the regenerative medicine company, announced on 11 November that it has reformed as a private enterprise and that its lead product, the cell therapy (VAVELTA®) will be evaluated by the US military to help treat injured soldiers.   Battlefield mortality has decreased from 30% in World War II to less than 10% in present day conflicts, partly as a result of better medical ca...


UHSM and Intercytex announce development of a strategic partnership to create a business to accelerate the translation of Regenerative Medicine

Regenerative medicine has the potential to play an increasingly vital role in delivering the next generation of healthcare, offering treatments or possible cures for areas of unmet medical need such as Parkinson’s, diabetes, stroke and heart disease. (David Willets July 2011)UHSM (University Hospital South Manchester)* and Intercytex** announce the development of a strategic partnership that...

Intercytex and UHSM announce two initial projects for their partnership in Cell Therapy and Regenerative Medicine

Intercytex and UHSM announce two initial projects for their partnership in Cell Therapy and Regenerative Medicine12th November 2013Intercytex Ltd and University Hospital South Manchester NHS Foundation Trust (‘UHSM’) today announced that their partnership in Cell Therapy and Regenerative Medicine is undertaking the development of a progressive clinical trials system and an advanced therapy man...

Monday 11th June 2018

Explained: Detecting the threat of nuclear weapons

Will the recent U.S. withdrawal from a 2015 accord that put restrictions on Iran’s

Tuesday 5th June 2018

Blue Apron Partners with the New York Botanical Garden

As a lead program partner of NYBG’s New Edible Academy, Blue Apron will inspire tens of thousands of kids and their families to plant, grow, harvest, and cook with seasonal ingredients Blue Apron (NYSE:APRN) today announced a partnership with the New York Botanical Garden (NYBG) to promote community well-being and raise awareness for the benefits of ...

Tuesday 22nd May 2018

Corning and SLS – a 15 year partnership

Corning is a long-standing partner of SLS, and has been attending the Scientific Laboratory Show and Conference since its inception. We spoke to Corning’s Joana Faustino-Kemp to find out why the company attends and what it has in store for visitors to this year’s show....

Tuesday 8th May 2018

CEVEC and CSL Limited sign exclusive license agreement for production of recombinant C1 Esterase Inhibitor using CEVEC's proprietary CAP(R)Go technology

DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Alliance 08.05.2018 / 08:30 The issuer is solely responsible for the content of this announcement. CEVEC and CSL Limited sign exclusive license agreement for production of recombinant C1 Esterase Inhibitor using CEVEC's proprietary CAP(R)Go technology   CAP(R)Go provides unique opportunity for CSL to develop

Wednesday 28th March 2018

CurePSP and the Rainwater Charitable Foundation Launch the Prime of Life Brain Initiative

The initiative will support neurodegeneration research with goal of finding treatment and cure CurePSP, the leading nonprofit advocacy organization for prime of life neurodegenerative diseases, and the Rainwater Charitable Foundation (RCF), today announced their landmark partnership in the Prime of Life Brain Initiative, an unprecedented research effor...

Monday 5th March 2018

Schools Must Include Well-Being and Mental Health in Curriculum

CMRubinWorld and top teachers around the world take on mental health and well-being and the ways in which schools and communities must address the problem. NEW YORK (PRWEB) March 05, 2018 Today’s students face many different environmental, social and economic challenges compared to the generations that came before them. What’s the link between worldwide shootings and mental health?&...

Tuesday 13th February 2018

UR2.Global Names London Musician and Producer – Aubrey Whitfield, as the 2018 Honorary Artist-In-Residence for Global Self-Esteem ARTS Project to Uplift Humanity

The UR2.Global Self-Esteem Project Offers Awards to Artists that Participate in an Artist Challenge to Uplift Women & Men in Institutions of Despair (PRWEB) February 13, 2018 UR2.Global names United Kingdom’s Aubrey Whitfield – producer, multi-instrumentalist, and singer-songwriter as its 2018 Honorary Artist-in-Residence (HAR) for its global grassroots humanitarian project which showcase...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks